propagermanium has been researched along with Hepatitis B, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, C; Ito, M; Oda, T; Okumura, M; Suzuki, H | 1 |
1 review(s) available for propagermanium and Hepatitis B, Chronic
| Article | Year |
|---|---|
Propagermanium: a nonspecific immune modulator for chronic hepatitis B.
Topics: Adjuvants, Immunologic; Alanine Transaminase; Double-Blind Method; Female; Germanium; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunity, Cellular; Interferon Inducers; Liver; Liver Failure, Acute; Male; Organometallic Compounds; Pilot Projects; Product Surveillance, Postmarketing; Propionates; Time Factors | 2003 |
1 trial(s) available for propagermanium and Hepatitis B, Chronic
| Article | Year |
|---|---|
Propagermanium: a nonspecific immune modulator for chronic hepatitis B.
Topics: Adjuvants, Immunologic; Alanine Transaminase; Double-Blind Method; Female; Germanium; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunity, Cellular; Interferon Inducers; Liver; Liver Failure, Acute; Male; Organometallic Compounds; Pilot Projects; Product Surveillance, Postmarketing; Propionates; Time Factors | 2003 |